Efficacy of mitomycin C in modified transcanalicular diode laser dacryocystorhinostomy
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista Brasileira de Oftalmologia (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802022000100216 |
Resumo: | ABSTRACT Objective: To evaluate the efficacy of mitomycin C in anatomical and functional success after modified transcanalicular diode laser dacryocystorhinostomy. Methods: A prospective, double-blinded, randomized placebo-controlled study compared the effect of topical mitomycin C on modified transcanalicular diode laser dacryocystorhinostomy. Group 1 had modified transcanalicular diode laser dacryocystorhinostomy with topical saline, while Group 2 had modified transcanalicular diode laser dacryocystorhinostomy with topical mitomycin C. Success was defined as anatomical patency and relief of symptoms at the end of 6 months. Results: Six months after surgery, Group 1 (30 patients) showed anatomical and functional success rates of 86.7% and 83.3%, respectively. Group 2 (32 patients) showed anatomical and functional success rates of 87.5% and 84.3%, respectively. There was no statistically significant difference between the groups 1 and 2 (p = 1.000). Conclusion: The use of mitomycin C did not improve the anatomical and functional success rates of modified transcanalicular diode laser dacryocystorhinostomy compared to placebo. |
id |
SBO-1_1d1db53aa2915eb9ceb2f0d7ac68aa56 |
---|---|
oai_identifier_str |
oai:scielo:S0034-72802022000100216 |
network_acronym_str |
SBO-1 |
network_name_str |
Revista Brasileira de Oftalmologia (Online) |
repository_id_str |
|
spelling |
Efficacy of mitomycin C in modified transcanalicular diode laser dacryocystorhinostomyLacrimal apparatus diseasesDacryocystorhinostomyDacryocystitisLasers, solid-stateABSTRACT Objective: To evaluate the efficacy of mitomycin C in anatomical and functional success after modified transcanalicular diode laser dacryocystorhinostomy. Methods: A prospective, double-blinded, randomized placebo-controlled study compared the effect of topical mitomycin C on modified transcanalicular diode laser dacryocystorhinostomy. Group 1 had modified transcanalicular diode laser dacryocystorhinostomy with topical saline, while Group 2 had modified transcanalicular diode laser dacryocystorhinostomy with topical mitomycin C. Success was defined as anatomical patency and relief of symptoms at the end of 6 months. Results: Six months after surgery, Group 1 (30 patients) showed anatomical and functional success rates of 86.7% and 83.3%, respectively. Group 2 (32 patients) showed anatomical and functional success rates of 87.5% and 84.3%, respectively. There was no statistically significant difference between the groups 1 and 2 (p = 1.000). Conclusion: The use of mitomycin C did not improve the anatomical and functional success rates of modified transcanalicular diode laser dacryocystorhinostomy compared to placebo.Sociedade Brasileira de Oftalmologia2022-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802022000100216Revista Brasileira de Oftalmologia v.81 2022reponame:Revista Brasileira de Oftalmologia (Online)instname:Sociedade Brasileira de Oftalmologia (SBO)instacron:SBO10.37039/1982.8551.20220035info:eu-repo/semantics/openAccessFeijó,Eduardo DamousDias,Mirna de MeloSouza,Bruna Angelina Alves deCaixeta,Juliana AlvesLimongi,Roberto MurilloMatayoshi,Suzanaeng2022-05-13T00:00:00Zoai:scielo:S0034-72802022000100216Revistahttps://rbo.emnuvens.com.br/rbo/indexhttps://old.scielo.br/oai/scielo-oai.phpsob@sboportal.org.br||rbo@sboportal.org.br1982-85510034-7280opendoar:2022-05-13T00:00Revista Brasileira de Oftalmologia (Online) - Sociedade Brasileira de Oftalmologia (SBO)false |
dc.title.none.fl_str_mv |
Efficacy of mitomycin C in modified transcanalicular diode laser dacryocystorhinostomy |
title |
Efficacy of mitomycin C in modified transcanalicular diode laser dacryocystorhinostomy |
spellingShingle |
Efficacy of mitomycin C in modified transcanalicular diode laser dacryocystorhinostomy Feijó,Eduardo Damous Lacrimal apparatus diseases Dacryocystorhinostomy Dacryocystitis Lasers, solid-state |
title_short |
Efficacy of mitomycin C in modified transcanalicular diode laser dacryocystorhinostomy |
title_full |
Efficacy of mitomycin C in modified transcanalicular diode laser dacryocystorhinostomy |
title_fullStr |
Efficacy of mitomycin C in modified transcanalicular diode laser dacryocystorhinostomy |
title_full_unstemmed |
Efficacy of mitomycin C in modified transcanalicular diode laser dacryocystorhinostomy |
title_sort |
Efficacy of mitomycin C in modified transcanalicular diode laser dacryocystorhinostomy |
author |
Feijó,Eduardo Damous |
author_facet |
Feijó,Eduardo Damous Dias,Mirna de Melo Souza,Bruna Angelina Alves de Caixeta,Juliana Alves Limongi,Roberto Murillo Matayoshi,Suzana |
author_role |
author |
author2 |
Dias,Mirna de Melo Souza,Bruna Angelina Alves de Caixeta,Juliana Alves Limongi,Roberto Murillo Matayoshi,Suzana |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Feijó,Eduardo Damous Dias,Mirna de Melo Souza,Bruna Angelina Alves de Caixeta,Juliana Alves Limongi,Roberto Murillo Matayoshi,Suzana |
dc.subject.por.fl_str_mv |
Lacrimal apparatus diseases Dacryocystorhinostomy Dacryocystitis Lasers, solid-state |
topic |
Lacrimal apparatus diseases Dacryocystorhinostomy Dacryocystitis Lasers, solid-state |
description |
ABSTRACT Objective: To evaluate the efficacy of mitomycin C in anatomical and functional success after modified transcanalicular diode laser dacryocystorhinostomy. Methods: A prospective, double-blinded, randomized placebo-controlled study compared the effect of topical mitomycin C on modified transcanalicular diode laser dacryocystorhinostomy. Group 1 had modified transcanalicular diode laser dacryocystorhinostomy with topical saline, while Group 2 had modified transcanalicular diode laser dacryocystorhinostomy with topical mitomycin C. Success was defined as anatomical patency and relief of symptoms at the end of 6 months. Results: Six months after surgery, Group 1 (30 patients) showed anatomical and functional success rates of 86.7% and 83.3%, respectively. Group 2 (32 patients) showed anatomical and functional success rates of 87.5% and 84.3%, respectively. There was no statistically significant difference between the groups 1 and 2 (p = 1.000). Conclusion: The use of mitomycin C did not improve the anatomical and functional success rates of modified transcanalicular diode laser dacryocystorhinostomy compared to placebo. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802022000100216 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802022000100216 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.37039/1982.8551.20220035 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Oftalmologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Oftalmologia |
dc.source.none.fl_str_mv |
Revista Brasileira de Oftalmologia v.81 2022 reponame:Revista Brasileira de Oftalmologia (Online) instname:Sociedade Brasileira de Oftalmologia (SBO) instacron:SBO |
instname_str |
Sociedade Brasileira de Oftalmologia (SBO) |
instacron_str |
SBO |
institution |
SBO |
reponame_str |
Revista Brasileira de Oftalmologia (Online) |
collection |
Revista Brasileira de Oftalmologia (Online) |
repository.name.fl_str_mv |
Revista Brasileira de Oftalmologia (Online) - Sociedade Brasileira de Oftalmologia (SBO) |
repository.mail.fl_str_mv |
sob@sboportal.org.br||rbo@sboportal.org.br |
_version_ |
1752122339572580352 |